Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Singapore Institute of Advanced Medicine Holdings Ltd. is extending its strategic partnership with biotech firm EnGeneIC Pty Limited, following promising developments in EnGeneIC’s proprietary technology, the EnGeneIC Dream Vector. The companies have agreed to a 180-day extension to finalize a Definitive Agreement, with EnGeneIC bound by certain exclusivity obligations during this period. This move signifies a deepening of the collaborative efforts in the manufacturing and distribution of EDV-based products and theranostics.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money